Skip to content

Depression: all studies

Page 1042 of 1,042: studies 10,411 to 10,414 of 10,414, newest first. Back to the depression overview

Research

Psychedelic Therapy: A Primer for Primary Care Clinicians—5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT)

Burton J. Tabaac, Kenneth Shinozuka, Anne Weisman et al. preprint

Background: 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), also officially known as Mebufotenin, is a naturally occurring serotonergic psychedelic alkaloid found in the venom of the Sonoran Desert toad (Incilius alvarius) and various plant species. Areas of Uncertainty: Trace levels of 5-MeO-DMT may be produced endogenously in humans, but its physiological role remains unclear. Safety profiles...

Psychedelic Therapy: A Primer for Primary Care Clinicians – Part III. N,N-dimethyltryptamine (DMT) and Ayahuasca

Kenneth Shinozuka, Burton J. Tabaac, Alejandro Arenas et al. preprint

Background: N,N-dimethyltryptamine (DMT) is a naturally-occurring serotonergic psychedelic found in natural plants around the globe. As the main psychoactive component in ayahuasca, which also contains monoamine oxidase (MAO) inhibitors, DMT has been consumed as plant-based brew by indigenous peoples for centuries. Further research is required to delineate the therapeutic utility of DMT.Areas...

Observational cohort study of a group-based VR program to improve mental health and wellbeing in people with life-threatening illnesses

Joe Hardy, Hannes Kettner, David R. Glowacki et al. preprint

Introduction. Being diagnosed with a life-threatening illness (LTI) is often accompanied by feelings of fear, uncertainty, and loneliness that can severely impact mental health. Relatively few interventions are available to address the existential concerns of individuals facing LTI, while treatment of the underlying physical ailment typically remains the priority of the healthcare system....

DOI: 10.31234/osf.io/rs8ny (opens in new tab) Virtual reality Mental health Serious illness Digital therapeutics

Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging

bioRxiv (Cold Spring Harbor Laboratory) Hanna M. Tolle, Andrea I. Luppi, Timothy Lawn et al. 1 citation preprint

Conventional antidepressants show moderate efficacy in treating major depressive disorder. Psychedelic-assisted therapy holds promise, yet individual responses vary, underscoring the need for predictive tools to guide treatment selection. Here, we present graphTRIP (graph-based Treatment Response Interpretability and Prediction) – a geometric deep learning architecture that enables three...

DOI: 10.1101/2025.07.02.662710 (opens in new tab) Psychedelic therapy Depression treatment Antidepressant therapy Mdd treatment +19